Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

European Commission approves Afinitor for new indication

Sep. 5, 2011

New acetyl-CoA carboxylase inhibitors claimed by Bayer Schering Pharma

Sep. 5, 2011

Novel carbonic anhydrase inhibitors patented by European investigators

Sep. 2, 2011

Data presented from metastatic colorectal cohort of phase II trial of Delcath chemosaturation system

Sep. 1, 2011

Kissei obtains Japanese rights to DNA topoisomerase 2 inhibitor for anthracycline extravasation

Sep. 1, 2011

Bristol-Myers and Health Canada issue new safety information regarding Sprycel

Sep. 1, 2011

Tarceva approved in E.U. for specific subtype of non-small cell lung cancer

Sep. 1, 2011

DSMB recommends continuation of pivotal X-PECT study of perifosine

Sep. 1, 2011

First patient dosed in phase I study of ZIN ATI-001

Aug. 31, 2011

Adamis Pharmaceuticals enrolls first patient into phase I/IIa study of APC-100

Aug. 31, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...
Other news to note for July 20, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Cellution, Dimerix, Elutia, IPG, Jasper, Kira, Lumibird, Medtronic,...